ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $309,000 | -91.5% | 7,644 | -87.9% | 0.00% | -90.0% |
| Q2 2015 | $3,649,000 | -68.7% | 63,401 | -65.4% | 0.03% | -69.4% |
| Q1 2015 | $11,659,000 | +34.0% | 183,123 | +29.9% | 0.10% | +30.7% |
| Q4 2014 | $8,701,000 | +75.6% | 140,941 | +10.5% | 0.08% | +66.7% |
| Q3 2014 | $4,955,000 | +18.7% | 127,597 | +5.3% | 0.04% | +18.4% |
| Q2 2014 | $4,174,000 | +105.3% | 121,140 | +157.5% | 0.04% | +31.0% |
| Q1 2014 | $2,033,000 | +76.8% | 47,037 | +62.9% | 0.03% | +70.6% |
| Q4 2013 | $1,150,000 | +92.3% | 28,869 | +81.4% | 0.02% | +54.5% |
| Q3 2013 | $598,000 | – | 15,918 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |